1. Home
  2. TCMD vs EOLS Comparison

TCMD vs EOLS Comparison

Compare TCMD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

HOLD

Current Price

$23.44

Market Cap

514.9M

Sector

Health Care

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.15

Market Cap

500.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCMD
EOLS
Founded
1995
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
514.9M
500.0M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
TCMD
EOLS
Price
$23.44
$7.15
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
★ $37.67
$15.00
AVG Volume (30 Days)
167.8K
★ 665.0K
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 17.14
1.23
EPS
★ 0.26
N/A
Revenue
N/A
★ $297,176,000.00
Revenue This Year
$9.98
$12.44
Revenue Next Year
$9.44
$17.37
P/E Ratio
$91.00
★ N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$14.84
$3.86
52 Week High
$37.77
$9.31

Technical Indicators

Market Signals
Indicator
TCMD
EOLS
Relative Strength Index (RSI) 56.49 40.67
Support Level $22.92 $7.07
Resistance Level $27.67 $7.28
Average True Range (ATR) 0.60 0.32
MACD 0.18 -0.03
Stochastic Oscillator 81.96 23.66

Price Performance

Historical Comparison
TCMD
EOLS

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: